Komodo Health Appoints Paul Thomas as Chief Financial Officer

Finance veteran to oversee financial strategy as demand for company’s AI platform accelerates

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the leader in AI-powered healthcare intelligence, today announced the promotion of Paul Thomas to Chief Financial Officer (CFO). In this role, Thomas, who has served as Senior Vice President of Finance and Acting CFO since April 2025, will oversee Komodo’s finance organization and enterprise financial strategy.

The appointment comes as the industry reaches an inflection point, with organizations moving beyond using AI as a productivity layer to building and operationalizing it as a core enterprise capability. Komodo is leading this shift with Marmot™, its AI analytics platform built on the Healthcare Map^®, the industry’s most comprehensive view of 330+ million patient journeys. Marmot enables organizations to move from static reporting and delayed insights to real-time, trusted intelligence and accelerate critical decision-making across the product life cycle, from trial design to launch strategy to post-market evidence generation.

As adoption of Marmot increases across healthcare and Life Sciences organizations, the ability to align capital allocation, investment strategy, and long-term platform development is essential to sustaining growth.

“Paul’s expertise has been instrumental in advancing Komodo's strong financial foundation and positioning us for our next phase of AI-led growth," said Web Sun, President and Co-Founder, Komodo Health. “As our customers move from treating AI as a productivity tool to embedding it as a core part of how they operate, the discipline and strategic alignment he brings will be essential as we continue to scale.”

Since joining Komodo, Thomas has played a central role in strengthening the company’s financial strategy, improving operational rigor and enabling disciplined investment across product innovation and go-to-market expansion. His leadership has helped ensure that Komodo can scale aggressively while continuing to invest in the infrastructure required to support enterprise-grade AI development and deployment.

“Komodo is building the AI-powered intelligence that is fundamentally changing how organizations make decisions," said Thomas. "My focus is on ensuring we have the financial strategy, systems, and discipline to support that growth while continuing to invest in the platform and capabilities that drive impact for our customers.”

Thomas brings more than 20 years of experience in private and public company finance, strategic planning, and investment research. Prior to Komodo, he led Strategic Finance and Investor Relations at Talkdesk and played a key role in taking Sumo Logic public in 2020. He began his career as a semiconductor engineer at Intel Corporation before moving into finance roles at Merrill Lynch, Bank of America, and Goldman Sachs.

About Komodo Health
Komodo Health is on a mission to reduce the global burden of disease by building foundational AI for how Life Sciences and healthcare organizations discover, develop, and deliver life-saving therapies. The company's healthcare-native AI platform Marmot, powered by its Healthcare Map, eliminates slow, fragmented analyses to accelerate critical healthcare decisions across the product life cycle — from trial design to launch strategy to post-market evidence generation. For more information, visit www.komodohealth.com.